Pro-fibrotic Factors as Potential Biomarkers of Anti-fibrotic Drug Therapy in Patients With Idiopathic Pulmonary Fibrosis.

MLA

Lopez-Lopez, Lidia, et al. “Pro-Fibrotic Factors as Potential Biomarkers of Anti-Fibrotic Drug Therapy in Patients With Idiopathic Pulmonary Fibrosis.” Archivos de Bronconeumologia, vol. 57, no. 3, Mar. 2021, pp. 231–33. EBSCOhost, https://doi.org/10.1016/j.arbres.2020.08.005.

APA

Lopez-Lopez, L., Cabrera Cesar, E., Lara, E., Hidalgo-San Juan, M. V., Parrado, C., Martín-Montañez, E., & Garcia-Fernandez, M. (2021). Pro-fibrotic Factors as Potential Biomarkers of Anti-fibrotic Drug Therapy in Patients With Idiopathic Pulmonary Fibrosis. Archivos de Bronconeumologia, 57(3), 231–233. https://doi.org/10.1016/j.arbres.2020.08.005

Chicago

Lopez-Lopez, Lidia, Eva Cabrera Cesar, Estrella Lara, M Victoria Hidalgo-San Juan, Concepcion Parrado, Elisa Martín-Montañez, and Maria Garcia-Fernandez. 2021. “Pro-Fibrotic Factors as Potential Biomarkers of Anti-Fibrotic Drug Therapy in Patients With Idiopathic Pulmonary Fibrosis.” Archivos de Bronconeumologia 57 (3): 231–33. doi:10.1016/j.arbres.2020.08.005.